Ascendis Pharma A/S (ASND)
222.08
-4.58
(-2.02%)
USD |
NASDAQ |
Apr 28, 16:00
222.09
+0.01
(+0.00%)
After-Hours: 20:00
Ascendis Pharma Research and Development Expense (TTM) : 332.30M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Novo Nordisk A/S | 7.923B |
| Evaxion AS | 9.988M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| Trinity Biotech Plc | 4.019M |
| DBV Technologies SA | 107.07M |